about
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are meta...
Read More
8.82
-0.30
(-3.29%)
556.5K
XNAS Volume
XNAS 27 Aug, 2025 4:08 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Regenxbio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..